HEADER STRUCTURAL GENOMICS, UNKNOWN FUNCTION 14-SEP-07 2RA8 TITLE CRYSTAL STRUCTURE OF THE Q64V53_BACFR PROTEIN FROM BACTEROIDES TITLE 2 FRAGILIS. NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET BFR43 COMPND MOL_ID: 1; COMPND 2 MOLECULE: UNCHARACTERIZED PROTEIN Q64V53_BACFR; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES FRAGILIS; SOURCE 3 ORGANISM_TAXID: 295405; SOURCE 4 STRAIN: YCH46; SOURCE 5 GENE: BF1877; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3)+MAGIC; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET21-23C KEYWDS Q64V53, WGR DOMAIN, LRR DOMAIN, LEUCINE RICH REPEATS, BFR43, NESG, KEYWDS 2 STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST KEYWDS 3 STRUCTURAL GENOMICS CONSORTIUM, UNKNOWN FUNCTION EXPDTA X-RAY DIFFRACTION AUTHOR S.M.VOROBIEV,M.ABASHIDZE,J.SEETHARAMAN,D.WANG,K.CUNNINGHAM, AUTHOR 2 M.MAGLAQUI,L.OWENS,R.XIAO,T.B.ACTON,G.T.MONTELIONE,J.F.HUNT,L.TONG, AUTHOR 3 NORTHEAST STRUCTURAL GENOMICS CONSORTIUM (NESG) REVDAT 3 13-JUL-11 2RA8 1 VERSN REVDAT 2 24-FEB-09 2RA8 1 VERSN REVDAT 1 25-SEP-07 2RA8 0 JRNL AUTH S.M.VOROBIEV,M.ABASHIDZE,J.SEETHARAMAN,D.WANG,K.CUNNINGHAM, JRNL AUTH 2 M.MAGLAQUI,L.OWENS,R.XIAO,T.B.ACTON,G.T.MONTELIONE,J.F.HUNT, JRNL AUTH 3 L.TONG JRNL TITL CRYSTAL STRUCTURE OF THE Q64V53_BACFR PROTEIN FROM JRNL TITL 2 BACTEROIDES FRAGILIS. JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.1 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.39 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 622181.640 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 79.4 REMARK 3 NUMBER OF REFLECTIONS : 44385 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.225 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1730 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.006 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.95 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.07 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 59.10 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 5339 REMARK 3 BIN R VALUE (WORKING SET) : 0.2590 REMARK 3 BIN FREE R VALUE : 0.2930 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 3.60 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 197 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.021 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2773 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 9.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 30.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.35000 REMARK 3 B22 (A**2) : -1.64000 REMARK 3 B33 (A**2) : 5.99000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 1.57000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.27 REMARK 3 ESD FROM SIGMAA (A) : 0.23 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.27 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.008 REMARK 3 BOND ANGLES (DEGREES) : 1.30 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 24.70 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.08 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.35 REMARK 3 BSOL : 60.85 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM REMARK 3 PARAMETER FILE 3 : ION.PARAM REMARK 3 PARAMETER FILE 4 : CAS_MOD1.PAR REMARK 3 PARAMETER FILE 5 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : ION.TOP REMARK 3 TOPOLOGY FILE 4 : CAS_MOD1.TOP REMARK 3 TOPOLOGY FILE 5 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: 1. THE FRIEDEL PAIRS WERE USED FOR REMARK 3 PHASING. 2. CYS 116 WAS MODIFIED TO S-(DIMETHYLARSENIC)CYSTEINE REMARK 3 BY CACODYLIC BUFFER. 3. TYR 316 IS LOCATED IN A GENEROUSLY REMARK 3 ALLOWED POSITION ON RAMACHANDRAN PLOT. HOWEVER, TYR 316 ELECTRON REMARK 3 DENSITY IS VERY WELL DEFINED AND COULD BE INTERPRETED REMARK 3 UNAMBIGUOUSLY. REMARK 4 REMARK 4 2RA8 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-SEP-07. REMARK 100 THE RCSB ID CODE IS RCSB044619. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 25-JUL-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97922 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 52396 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.3 REMARK 200 DATA REDUNDANCY : 1.900 REMARK 200 R MERGE (I) : 0.05800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 14.3500 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.02 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.90 REMARK 200 R MERGE FOR SHELL (I) : 0.23900 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.250 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: THE STRUCTURE FACTOR FILE CONTAINS FRIEDEL PAIRS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.91 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16-18% PEG 3350, 0.2M MAGNESIUM REMARK 280 ACETATE, 0.1M CACODYLIC ACID PH 6.5, VAPOR DIFFUSION, HANGING REMARK 280 DROP, TEMPERATURE 291K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 54.13050 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 32.61850 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 54.13050 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 32.61850 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: DIMER ACCORDING TO THE AGGREGATION ANALYSIS; SECOND PART OF REMARK 300 THE BIOLOGICAL ASSEMBLY IS GENERATED BY -X+1,Y,-Z+1 SYMMETRY REMARK 300 OPERATOR. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 86.62900 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 55.97336 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 515 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASP A 344 REMARK 465 ASP A 345 REMARK 465 ASP A 346 REMARK 465 TYR A 347 REMARK 465 SER A 348 REMARK 465 TYR A 349 REMARK 465 HIS A 358 REMARK 465 HIS A 359 REMARK 465 HIS A 360 REMARK 465 HIS A 361 REMARK 465 HIS A 362 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 MSE A 1 CG SE CE REMARK 470 LYS A 11 CG CD CE NZ REMARK 470 LYS A 51 CG CD CE NZ REMARK 470 TYR A 343 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 HIS A 357 CG ND1 CD2 CE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 CYS A 124 31.32 -98.61 REMARK 500 GLN A 154 136.23 -178.36 REMARK 500 GLU A 264 58.98 -99.18 REMARK 500 ALA A 288 10.69 55.31 REMARK 500 HIS A 302 47.75 -143.17 REMARK 500 LYS A 307 -5.47 -58.00 REMARK 500 TYR A 316 104.46 77.84 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 401 DISTANCE = 5.38 ANGSTROMS REMARK 525 HOH A 487 DISTANCE = 6.60 ANGSTROMS REMARK 525 HOH A 490 DISTANCE = 6.32 ANGSTROMS REMARK 525 HOH A 493 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH A 496 DISTANCE = 5.45 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: BFR43 RELATED DB: TARGETDB DBREF 2RA8 A 1 354 UNP Q64V53 Q64V53_BACFR 1 354 SEQADV 2RA8 LEU A 355 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 GLU A 356 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 HIS A 357 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 HIS A 358 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 HIS A 359 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 HIS A 360 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 HIS A 361 UNP Q64V53 EXPRESSION TAG SEQADV 2RA8 HIS A 362 UNP Q64V53 EXPRESSION TAG SEQRES 1 A 362 MSE LYS ARG VAL PHE VAL PHE GLN ASP PHE LYS SER GLN SEQRES 2 A 362 LYS PHE TRP SER ILE ASP VAL ARG GLY THR ASP VAL ILE SEQRES 3 A 362 VAL ASN TYR GLY LYS LEU GLY THR ASP GLY GLN THR GLN SEQRES 4 A 362 VAL LYS ASN PHE SER SER ALA GLY GLU ALA GLU LYS ALA SEQRES 5 A 362 ALA GLY LYS LEU ILE ALA GLU LYS THR LYS LYS GLY TYR SEQRES 6 A 362 VAL GLU THR LEU GLU GLU VAL ALA LYS GLU MSE LYS VAL SEQRES 7 A 362 GLU ALA LYS LYS TYR ALA LEU SER TYR ASP GLU ALA GLU SEQRES 8 A 362 GLU GLY VAL ASN LEU MSE ASP LYS ILE LEU LYS ASP LYS SEQRES 9 A 362 LYS LEU PRO SER LEU LYS GLN ILE THR ILE GLY CAS TRP SEQRES 10 A 362 GLY TYR GLU GLY GLU ASP CYS SER ASP ILE ALA ASP GLY SEQRES 11 A 362 ILE VAL GLU ASN LYS GLU LYS PHE ALA HIS PHE GLU GLY SEQRES 12 A 362 LEU PHE TRP GLY ASP ILE ASP PHE GLU GLU GLN GLU ILE SEQRES 13 A 362 SER TRP ILE GLU GLN VAL ASP LEU SER PRO VAL LEU ASP SEQRES 14 A 362 ALA MSE PRO LEU LEU ASN ASN LEU LYS ILE LYS GLY THR SEQRES 15 A 362 ASN ASN LEU SER ILE GLY LYS LYS PRO ARG PRO ASN LEU SEQRES 16 A 362 LYS SER LEU GLU ILE ILE SER GLY GLY LEU PRO ASP SER SEQRES 17 A 362 VAL VAL GLU ASP ILE LEU GLY SER ASP LEU PRO ASN LEU SEQRES 18 A 362 GLU LYS LEU VAL LEU TYR VAL GLY VAL GLU ASP TYR GLY SEQRES 19 A 362 PHE ASP GLY ASP MSE ASN VAL PHE ARG PRO LEU PHE SER SEQRES 20 A 362 LYS ASP ARG PHE PRO ASN LEU LYS TRP LEU GLY ILE VAL SEQRES 21 A 362 ASP ALA GLU GLU GLN ASN VAL VAL VAL GLU MSE PHE LEU SEQRES 22 A 362 GLU SER ASP ILE LEU PRO GLN LEU GLU THR MSE ASP ILE SEQRES 23 A 362 SER ALA GLY VAL LEU THR ASP GLU GLY ALA ARG LEU LEU SEQRES 24 A 362 LEU ASP HIS VAL ASP LYS ILE LYS HIS LEU LYS PHE ILE SEQRES 25 A 362 ASN MSE LYS TYR ASN TYR LEU SER ASP GLU MSE LYS LYS SEQRES 26 A 362 GLU LEU GLN LYS SER LEU PRO MSE LYS ILE ASP VAL SER SEQRES 27 A 362 ASP SER GLN GLU TYR ASP ASP ASP TYR SER TYR PRO MSE SEQRES 28 A 362 ILE THR GLU LEU GLU HIS HIS HIS HIS HIS HIS MODRES 2RA8 MSE A 1 MET SELENOMETHIONINE MODRES 2RA8 MSE A 76 MET SELENOMETHIONINE MODRES 2RA8 MSE A 97 MET SELENOMETHIONINE MODRES 2RA8 CAS A 116 CYS S-(DIMETHYLARSENIC)CYSTEINE MODRES 2RA8 MSE A 171 MET SELENOMETHIONINE MODRES 2RA8 MSE A 239 MET SELENOMETHIONINE MODRES 2RA8 MSE A 271 MET SELENOMETHIONINE MODRES 2RA8 MSE A 284 MET SELENOMETHIONINE MODRES 2RA8 MSE A 314 MET SELENOMETHIONINE MODRES 2RA8 MSE A 323 MET SELENOMETHIONINE MODRES 2RA8 MSE A 333 MET SELENOMETHIONINE MODRES 2RA8 MSE A 351 MET SELENOMETHIONINE HET MSE A 1 5 HET MSE A 76 8 HET MSE A 97 8 HET CAS A 116 9 HET MSE A 171 8 HET MSE A 239 8 HET MSE A 271 8 HET MSE A 284 8 HET MSE A 314 8 HET MSE A 323 8 HET MSE A 333 8 HET MSE A 351 8 HETNAM MSE SELENOMETHIONINE HETNAM CAS S-(DIMETHYLARSENIC)CYSTEINE FORMUL 1 MSE 11(C5 H11 N O2 SE) FORMUL 1 CAS C5 H12 AS N O2 S FORMUL 2 HOH *230(H2 O) HELIX 1 1 SER A 45 LYS A 63 1 19 HELIX 2 2 LEU A 69 MSE A 76 1 8 HELIX 3 3 SER A 86 GLU A 92 1 7 HELIX 4 4 ASN A 95 ASP A 103 1 9 HELIX 5 5 LYS A 105 LEU A 109 5 5 HELIX 6 6 CYS A 124 GLU A 133 1 10 HELIX 7 7 ASN A 134 ALA A 139 1 6 HELIX 8 8 GLU A 155 ILE A 159 5 5 HELIX 9 9 LEU A 164 ALA A 170 1 7 HELIX 10 10 PRO A 206 SER A 216 1 11 HELIX 11 11 VAL A 230 GLY A 234 5 5 HELIX 12 12 ASP A 238 PHE A 246 5 9 HELIX 13 13 GLU A 264 SER A 275 1 12 HELIX 14 14 ILE A 277 LEU A 281 5 5 HELIX 15 15 THR A 292 ASP A 301 1 10 HELIX 16 16 HIS A 302 LYS A 307 1 6 HELIX 17 17 SER A 320 LEU A 331 1 12 HELIX 18 18 THR A 353 HIS A 357 5 5 SHEET 1 A 5 GLN A 37 ASN A 42 0 SHEET 2 A 5 ASP A 24 LYS A 31 -1 N TYR A 29 O GLN A 37 SHEET 3 A 5 GLN A 13 ARG A 21 -1 N ASP A 19 O ILE A 26 SHEET 4 A 5 ARG A 3 GLN A 8 -1 N PHE A 7 O LYS A 14 SHEET 5 A 5 VAL A 66 GLU A 67 -1 O VAL A 66 N VAL A 6 SHEET 1 B10 ALA A 80 TYR A 83 0 SHEET 2 B10 GLN A 111 ILE A 114 1 O THR A 113 N TYR A 83 SHEET 3 B10 GLY A 143 TRP A 146 1 O PHE A 145 N ILE A 114 SHEET 4 B10 ASN A 176 LYS A 180 1 O LYS A 178 N TRP A 146 SHEET 5 B10 SER A 197 ILE A 201 1 O ILE A 201 N ILE A 179 SHEET 6 B10 LYS A 223 TYR A 227 1 O VAL A 225 N ILE A 200 SHEET 7 B10 TRP A 256 VAL A 260 1 O GLY A 258 N LEU A 226 SHEET 8 B10 THR A 283 ASP A 285 1 O ASP A 285 N LEU A 257 SHEET 9 B10 PHE A 311 ASN A 313 1 O PHE A 311 N MSE A 284 SHEET 10 B10 LYS A 334 ASP A 336 1 O ASP A 336 N ILE A 312 LINK C MSE A 1 N LYS A 2 1555 1555 1.33 LINK C GLU A 75 N MSE A 76 1555 1555 1.33 LINK C MSE A 76 N LYS A 77 1555 1555 1.33 LINK C LEU A 96 N MSE A 97 1555 1555 1.32 LINK C MSE A 97 N ASP A 98 1555 1555 1.33 LINK C GLY A 115 N CAS A 116 1555 1555 1.32 LINK C CAS A 116 N TRP A 117 1555 1555 1.33 LINK C ALA A 170 N MSE A 171 1555 1555 1.33 LINK C MSE A 171 N PRO A 172 1555 1555 1.34 LINK C ASP A 238 N MSE A 239 1555 1555 1.33 LINK C MSE A 239 N ASN A 240 1555 1555 1.33 LINK C GLU A 270 N MSE A 271 1555 1555 1.33 LINK C MSE A 271 N PHE A 272 1555 1555 1.33 LINK C THR A 283 N MSE A 284 1555 1555 1.33 LINK C MSE A 284 N ASP A 285 1555 1555 1.32 LINK C ASN A 313 N MSE A 314 1555 1555 1.33 LINK C MSE A 314 N LYS A 315 1555 1555 1.33 LINK C GLU A 322 N MSE A 323 1555 1555 1.33 LINK C MSE A 323 N LYS A 324 1555 1555 1.33 LINK C PRO A 332 N MSE A 333 1555 1555 1.33 LINK C MSE A 333 N LYS A 334 1555 1555 1.32 LINK C PRO A 350 N MSE A 351 1555 1555 1.33 LINK C MSE A 351 N ILE A 352 1555 1555 1.33 CRYST1 108.261 65.237 60.008 90.00 111.13 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.009237 0.000000 0.003569 0.00000 SCALE2 0.000000 0.015329 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017865 0.00000 HETATM 1 N MSE A 1 77.100 10.840 17.809 1.00 41.67 N HETATM 2 CA MSE A 1 76.393 11.764 16.879 1.00 36.65 C HETATM 3 C MSE A 1 74.914 11.718 17.128 1.00 26.75 C HETATM 4 O MSE A 1 74.312 10.638 17.164 1.00 28.58 O HETATM 5 CB MSE A 1 76.695 11.384 15.427 1.00 36.88 C